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and thapsigargin was attenuated by AICAR in articular chondro-
cytes.
Conclusions: Certain inﬂammatory stimuli suppress AMPK ac-
tivation in articular chondrocytes. Moreover, AMPKα knockdown
by RNAi enhances pro-catabolic responses of articular chon-
drocytes. Conversely, pharmacologic AMPK activation attenuates
articular chondrocyte pro-catabolic and hypertrophic differentiation
responses to inﬂammatory cytokines and alleviates the ER stress
response. Because human OA knee articular chondrocytes ex-
hibited attenuated AMPKα activation, our results provide the ﬁrst
evidence that therapeutic activation of AMPK has the potential to
inhibit the progression of OA.
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Purpose: Inﬂammatory cytokine Interleukin-1 (IL-1β) stimulates
reactive oxygen species (ROS), which mediates downstream cell
signaling, modulating catabolic and inﬂammatory gene expression
such as inducible nitric oxide synthase (iNOS) and cyclooxygenase
2 (COX2). The nutritional and antioxidant factor selenium (Se), has
long been considered to play an important role in Osteoarthritis
(OA). The ability of Se to neutralize reactive oxygen and nitrogen
species is one potential chondroprotective mechanism against OA
progression. In this study, we test if Se can neutralize inﬂammatory
and catabolic effects of IL-1β and examine the common signaling
pathways involved.
Methods: Primary chondrocytes and treatment. Primary human
chondrocytes were isolated by enzymatic digestion as previously
described from nonlesional cartilage of patients undergoing total
knee replacement surgery. Chondrocytes were pretreated with
and without 0.5 μM SelenoMethionine (SeMet) for 24 hrs and then
followed by 50 pg/ml or 100 pg/ml 1L-1β treatment for up to 24
hrs.
RNA isolation and Real Time RT-PCR. Total RNA was extracted
and reverse transcribed into cDNA for Real Time RT-PCR analy-
sis. The ABI Prism 7000 sequence detection system and relative
quantiﬁcation software (Applied Biosystems, Foster City, CA) were
used for real-time analyses. Analysis of relative mRNA expression
levels of iNOS and COX2 were normalized to 18S gene expres-
sion. Values are the mean (SEM) percentage as a percentage of
IL-1β induced iNOS and COX2 mRNA levels for three independent
experiments, conducted in triplicate. The relative mRNA level in
cells treated with IL-1β alone was set at 100%.
Immunoblotting and Phosphorylation Assay. Whole cell lysates
from chondrocytes for each tested condition were separated by
electrophoresis on reducing gradient gels, and transferred to ni-
trocellulose for immunoblotting. Membranes were blocked with 5%
BSA in TBS/0.1% Tween 20 (TBS-T). Polyclonal primary antibod-
ies against Phospho-p44/42 MAPK 3(Erk1/2), Phospho-p38 MAPK
(Thr180/Tyr182), Phospho-SAPK/JNK (Thr183/Tyr185), Phospho-
IKKα/β (Ser 176/180) Phospho- NF-kB p65 (Ser 536) were ob-
tained from Cell Signaling Technology (Danvers, MA) and used
at 1:1000 dilution. A monoclonal antibody against tubulin (Sigma)
was used as a normalization control at 1:10,000 dilution. Anti-
rabbit and anti-mouse IgG-HRP (Jackson ImmunoResearch, West
Grove, PA) secondary antibodies were diluted 1:50,000. The re-
sults shown are representative of two independent experiments,
conducted in duplicate.
Results: Pretreatment of chondrocytes with SeMet signiﬁcantly
inhibited the IL-1β induced iNOS gene expression (by ∼30%) and
COX2 gene expression (by ∼40%), Figure 1. Furthermore, SeMet
Figure 1. Pretreatment of SeMet inhibits IL-1β induced iNOS and COX2 mRNA
levels.
Figure 2. The effect of selenium pretreatment on the IL-1β induced signaling
pathways.
selectively inhibited IL-1β activated p38 MAPK and NF-kB activity,
but not JNK, ERK and IKKα/β activity (Figure 2, Western blot).
Conclusions: Taken together, our data show that Se can partially
reverse IL-1β induced iNOS and COX2 gene expression, and
shows evidence of altering IL-1β activated cell signaling. These
results suggest that one mechanism by which Se may exert a
chondroprotective effect is through regulation of cell signaling
pathways induced by pro-inﬂammatory cytokines.
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Purpose: As adiposity rather than simply excess in body mass
has been shown to be detrimental to the knee joint, increasing
studies have been undertaken to determine the role of adipokines
in osteoarthritis (OA). However, contradictory data have been
found for the expression and the effects of these adipose-derived
proteins in chondrocytes. This study investigated therefore the
effects of phenotypic modulation on the expression of adipokines
and their receptors in human chondrocytes.
Methods: The expression of adipokines (leptin and adiponectin)
and their receptors (AdipoR1, AdipoR2 and Ob-R) was examined
by quantitative real-time RT-PCR in chondrocytes obtained from
patients with osteoarthritis (OA) either directly after cells harvest
or after culture in monolayer or in alginate bead which is known
to restore and/or maintain the differentiated state of chondrocytes.
The change in transcript level of collagens type 1, 2A and 2B,
aggrecan and Sox9 was used to evaluate phenotypic modulation.
Results: The results indicated that leptin, adiponectin, AdipoR1
and Ob-R were expressed in freshly isolated chondrocytes while
AdipoR2 was barely detected. Major changes in the gene expres-
sion pattern occurred after culture in monolayer with a shift from
